HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Aneesh B Singhal Selected Research

Therapeutics

11/2021Impact of Pre-Stroke Antiplatelet Use on 3-Month Outcome After Ischemic Stroke.
8/2021Impact of revascularization therapies on outcome of posterior circulation ischemic stroke: The Indo-US stroke project.
1/2018An optimal Wilcoxon-Mann-Whitney test of mortality and a continuous outcome.
12/2017Normobaric hyperoxygenation: a potential neuroprotective therapy for acute ischemic stroke?
7/2017High-flow oxygen therapy for treatment of acute migraine: A randomized crossover trial.
2/2014Cerebrovascular disorders complicating pregnancy.
9/2012Dynamic functional cerebral blood volume responses to normobaric hyperoxia in acute ischemic stroke.
3/2012Evaluating effects of normobaric oxygen therapy in acute stroke with MRI-based predictive models.
5/2011Effect of normobaric oxygen therapy in a rat model of intracerebral hemorrhage.
7/2009Combination therapy with normobaric oxygen (NBO) plus thrombolysis in experimental ischemic stroke.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Aneesh B Singhal Research Topics

Disease

33Stroke (Strokes)
01/2022 - 03/2002
23Ischemic Stroke
11/2021 - 09/2003
9Infarction (Infarctions)
01/2020 - 05/2008
4Hemorrhage
11/2021 - 06/2003
4Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage)
04/2021 - 10/2004
4Hyperoxia
03/2007 - 04/2005
3Atrial Fibrillation
04/2021 - 10/2010
3Intracranial Hemorrhages (Intracranial Hemorrhage)
04/2021 - 07/2009
3Migraine Disorders (Migraine)
07/2017 - 08/2011
3Hypertension (High Blood Pressure)
03/2014 - 04/2005
3Hyperglycemia
02/2012 - 07/2005
2Critical Illness (Critically Ill)
08/2021 - 08/2021
2COVID-19
08/2021 - 08/2021
2Myocardial Infarction
04/2021 - 01/2016
2Hypotension (Low Blood Pressure)
01/2019 - 01/2017
2Sleep Initiation and Maintenance Disorders (Insomnia)
01/2019 - 01/2017
2Hyponatremia
01/2019 - 01/2017
2Infections
01/2019 - 01/2017
2Brain Ischemia (Cerebral Ischemia)
01/2018 - 11/2013
2Disease Progression
06/2017 - 03/2014
2Inflammation (Inflammations)
02/2017 - 01/2006
2Brain Edema (Cerebral Edema)
01/2016 - 04/2014
1Subdural Hematoma (Subdural Hemorrhage)
04/2021
1Endocarditis
01/2020
1Brain Neoplasms (Brain Tumor)
03/2019
1Pain (Aches)
07/2017
1Cluster Headache (Cluster Headaches)
07/2017
1Nausea
07/2017
1Septic Shock (Toxic Shock Syndrome)
03/2017
1Pneumonia (Pneumonitis)
03/2017
1Vasculitis (Vasculitides)
02/2017
1Primary angiitis of the central nervous system
02/2017
1Edema (Dropsy)
04/2014
1Headache (Headaches)
03/2014
1Aphasia (Dysphasia)
11/2013
1Ischemia
07/2012
1Cerebral Hemorrhage
05/2011
1Coronary Artery Disease (Coronary Atherosclerosis)
10/2010
1Heart Failure
10/2010
1Cerebral Infarction
07/2009
1Thrombosis (Thrombus)
01/2009
1Cerebrovascular Disorders (Cerebrovascular Occlusion)
03/2007
1Diabetes Mellitus
07/2005
1Communicable Diseases (Infectious Diseases)
07/2005
1Guillain-Barre Syndrome
04/2005
1Hemorrhagic Stroke
04/2005
1Posterior Leukoencephalopathy Syndrome
04/2005
1Leukoencephalopathies
04/2005
1Intracranial Vasospasm
10/2004
1Aneurysm (Aneurysms)
06/2003

Drug/Important Bio-Agent (IBA)

15Oxygen (Dioxygen)IBA
01/2018 - 03/2002
6Tissue Plasminogen Activator (Alteplase)FDA Link
11/2013 - 10/2004
4Biomarkers (Surrogate Marker)IBA
01/2020 - 07/2012
4Neuroprotective AgentsIBA
09/2012 - 08/2005
3Heparin (Liquaemin)FDA LinkGeneric
08/2021 - 06/2019
3Warfarin (Coumadin)FDA LinkGeneric
04/2021 - 11/2008
3Pharmaceutical PreparationsIBA
02/2017 - 08/2005
3Blood Glucose (Blood Sugar)IBA
10/2010 - 07/2005
2Factor Xa (Coagulation Factor Xa)IBA
04/2021 - 01/2016
2edoxabanIBA
04/2021 - 01/2016
2Natalizumab (Tysabri)FDA Link
01/2020 - 03/2017
2BenzodiazepinesIBA
01/2019 - 01/2017
2Glucose (Dextrose)FDA LinkGeneric
12/2014 - 05/2009
2Matrix Metalloproteinase 9 (Gelatinase B)IBA
04/2014 - 04/2005
1Clopidogrel (Plavix)FDA Link
01/2022
1Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
01/2022
1Dihydrotachysterol (AT 10)IBA
07/2017
1Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA
06/2017
1Cell Adhesion MoleculesIBA
03/2017
1IntegrinsIBA
03/2017
1Sympathomimetics (Sympathomimetic Amines)IBA
02/2017
1Antidepressive Agents (Antidepressants)IBA
09/2016
1IceIBA
01/2016
1Sulfonylurea ReceptorsIBA
04/2014
1Glyburide (Glibenclamide)FDA LinkGeneric
04/2014
1Transient Receptor Potential ChannelsIBA
04/2014
1Calcium Channel Blockers (Blockers, Calcium Channel)IBA
03/2014
1Vasodilator Agents (Vasodilators)IBA
03/2014
1Collagenases (Collagenase)FDA Link
05/2011
1Hemoglobins (Hemoglobin)IBA
01/2011
1Cytidine Triphosphate (CTP)IBA
01/2010
1Indicators and Reagents (Reagents)IBA
01/2009
1Free RadicalsIBA
11/2006
1Neurotransmitter Agents (Neurotransmitter)IBA
01/2006
1Insulin (Novolin)FDA Link
07/2005
1Superoxides (Superoxide)IBA
04/2005
1Intravenous Immunoglobulins (IVIG)FDA Link
04/2005
1JNK Mitogen-Activated Protein KinasesIBA
04/2002
1Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
04/2002

Therapy/Procedure

19Therapeutics
11/2021 - 09/2003
3Thrombectomy
01/2022 - 01/2020
3Length of Stay
03/2019 - 07/2005
3Hyperbaric Oxygenation
03/2007 - 03/2002
1Critical Care (Surgical Intensive Care)
08/2021
1Long-Term Care
01/2018
1Glycemic Control
05/2009
1Stem Cell Transplantation
08/2005
1Thrombolytic Therapy
04/2005
1Craniotomy
10/2004
1Catheters
06/2003